论文部分内容阅读
乙型慢性活动性肝炎(以下称慢活肝)和肝炎后肝硬化(以下称肝硬化),治疗比较困难,国内虽有各种药物治疗的报道,但多缺乏严格对照组,确切疗效难以评定。本组病例采用北京第四制药厂的去甲斑蟊素片(norcan-tharidin)用随机双盲对照法进行研究,获得较好疗效,报道如下。
B chronic active hepatitis (hereinafter referred to as slow living liver) and hepatitis cirrhosis (hereinafter referred to as cirrhosis), the treatment is more difficult, although there are various reports of drug treatment in China, but the lack of strict control group, the exact effect of difficult to assess . This group of patients using Beijing No. 4 Pharmaceutical Factory Norcantha element (norcan-tharidin) with a randomized double-blind control method to study, get better curative effect, reported as follows.